Civil Litigation
Oct. 17, 2019
Drug company ordered to arbitrate dispute over cancer treatment
A Los Angeles judge granted a San Diego pharmaceutical company’s motion to compel arbitration in a dispute involving an accusation that billionaire Patrick Soon-Shiong’s drug companies engaged in a scheme to buy, then intentionally tank, a competing cancer drug to secure market dominance and avoid a $1.2 billion contract payment.
A Los Angeles judge granted a San Diego pharmaceutical company's motion to compel arbitration in a dispute involving an accusation that billionaire Patrick Soon-Shiong's drug companies engaged in a scheme to buy, then intentionally tank, a competing cancer drug to secure market dominance and avoid a $1.2 billion contract payment.
Shortly after the suit was filed in May, Soon-Shiong said in a statement, "Because it is totally without...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Civil Litigation, Intellectual Property
San Diego biotech company alleges ‘catch and kill’ scheme to block competitive drug
By Nicolas Sonnenburg
